Columbia Asia Hospital Bukit Jalil has unveiled its new Cardiac Catheterisation Laboratory (Cath Lab), a significant enhancement to its heart and vascular care services. The launch, officiated by the hospital’s CEO, Sharonpal Singh, and Consultant Cardiologist Prem Nathan Arumuganathan, marks a continued investment in specialist capabilities since the hospital’s opening in 2023.
The Cath Lab aims to address Malaysia’s pressing heart disease concerns, as ischaemic heart disease remains the leading cause of death, according to the Department of Statistics Malaysia’s 2024 report. The facility provides faster, minimally invasive treatments, crucial for early detection and intervention.
Sharonpal Singh emphasised the importance of the new lab, stating, “This facility enables faster, minimally invasive treatment and improved access to specialist care, closer to home.” The lab is expected to significantly improve patient outcomes by offering advanced procedures that were previously less accessible.
The launch of the Cath Lab is part of Columbia Asia Hospital’s broader strategy to expand its cardiac care services, ensuring that patients receive timely and effective treatment. This development not only enhances the hospital’s capabilities but also strengthens its role in combating heart disease in Malaysia.
As the hospital continues to invest in state-of-the-art medical facilities, the new Cath Lab is poised to play a pivotal role in reducing the burden of heart disease, providing patients with the care they need without the need to travel far from home.
